Legal Representation
Attorney
Mark A. Paskar
USPTO Deadlines
Application History
33 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 14, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 14, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 18, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 16, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 16, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 16, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 16, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 14, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 14, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 14, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 18, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 16, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 16, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 16, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 10, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 8, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 8, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 8, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 9, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 14, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 14, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 24, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 18, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 27, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 28, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 27, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 27, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 28, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 28, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 28, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 25, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 12, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 7, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical injectable drugs for the treatment and prevention of cancer, cardiovascular disease, infections, pain, arthritis, psoriasis, diabetes, multiple sclerosis, anemia, hepatitis, hemophilia, osteoporosis, asthma, cystic fibrosis, pancreatitis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, systemic lupus erythematous, macular degeneration, migraines, growth hormone deficiency, chronic idiopathic urticaria, infertility, paroxysmal nocturnal hemoglobinuria, pneumonia, respiratory syncytial virus, varicella virus, human papillomavirus, and meningococcal disease
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"INJECTABLES"